Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon. | Cell Mol Life Sci | 2024 | 39136771 | PubTator, text mining | PubMed |
| Development of PROTACS degrading KRAS and SOS1. | Oncol Res | 2024 | 39055890 | PubTator, text mining | PubMed |
| Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. | Expert Rev Hematol | 2024 | 39054911 | PubTator, text mining | PubMed |
| Prenatal diagnosis of familial 3p26.3p25.3 deletion in a pregnancy associated with a favorable fetal outcome and asymptomatic carrier parent and family members in three generations. | Taiwan J Obstet Gynecol | 2024 | 39004488 | PubTator, text mining | PubMed |
| Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells. | Bioorg Chem | 2024 | 39002513 | PubTator, text mining | PubMed |
| Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. | J Med Chem | 2024 | 38991141 | PubTator, text mining | PubMed |
| Ubiquitin recruiting chimera: more than just a PROTAC. | Biol Direct | 2024 | 38978100 | PubTator, text mining | PubMed |
| Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling. | FEBS J | 2024 | 38975872 | PubTator, text mining | PubMed |
| PROTAC Beyond Cancer- Exploring the New Therapeutic Potential of Proteolysis Targeting Chimeras. | Curr Top Med Chem | 2024 | 38963108 | PubTator, text mining | PubMed |
| Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma. | Biomolecules | 2024 | 38927128 | PubTator, text mining | PubMed |
| Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives. | Bioorg Med Chem Lett | 2024 | 38917956 | PubTator, text mining | PubMed |
| Unveiling a new strategy for PDIA1 inhibition: Integration of activity-based probes profiling and targeted degradation. | Bioorg Chem | 2024 | 38917491 | PubTator, text mining | PubMed |
| CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer. | Biomed Pharmacother | 2024 | 38906024 | PubTator, text mining | PubMed |
| The emerging role of targeted protein degradation to treat and study cancer. | J Pathol | 2024 | 38886898 | PubTator, text mining | PubMed |
| Lessons from natural molecular glue degraders. | Biochem Soc Trans | 2024 | 38864421 | PubTator, text mining | PubMed |
| Discovery of a Promising CBP/p300 Degrader XYD129 for the Treatment of Acute Myeloid Leukemia. | J Med Chem | 2024 | 38829718 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of BCL-2 Targeting PROTACs. | Chemistry | 2024 | 38818652 | PubTator, text mining | PubMed |
| Evolution and impact of molecular glue research: a bibliometric analysis from 2000 to 2023. | Front Oncol | 2024 | 38817889 | PubTator, text mining | PubMed |
| Old drug, new use: The thalidomide-based fluorescent probe for cysteine detection and imaging in living cells. | Bioorg Chem | 2024 | 38810484 | PubTator, text mining | PubMed |
| IKZF2 Degradation: It's Time to Take into Account it When Designing Cereblon-Based PROTACs. | Chembiochem | 2024 | 38802326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=20